Cargando…

Phase 2 study of first‐line pembrolizumab monotherapy in elderly patients with non‐small‐cell lung cancer expressing high PD‐L1

BACKGROUND: Pembrolizumab is the recommended first‐line therapy for patients with advanced non‐small‐cell lung cancer (NSCLC) and a programmed death ligand‐1 (PD‐L1) tumor proportion score (TPS) of ≥50% without driver mutations. However, its efficacy and safety for patients ≥75 years have not been p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuda, Takeshi, Fujitaka, Kazunori, Suzuki, Tomoko, Hamai, Kosuke, Matsumoto, Naoko, Matsumura, Mirai, Isoyama, Shoko, Ueno, Sayaka, Mito, Mineyo, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Kawano, Reo, Masuda, Ken, Nishino, Ryohei, Ishikawa, Nobuhisa, Yamasaki, Masahiro, Hattori, Noboru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161325/ https://www.ncbi.nlm.nih.gov/pubmed/35488720 http://dx.doi.org/10.1111/1759-7714.14428

Ejemplares similares

Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study
por: Isoyama, Shoko, et al.
Publicado: (2022)

First‐line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD‐L1: A case report
por: Hamai, Kosuke, et al.
Publicado: (2020)

Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer
por: Masuda, Takeshi, et al.
Publicado: (2020)

Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer
por: Watari, Naokazu, et al.
Publicado: (2022)

Quantitative parameters of lymphocyte nuclear morphology in bronchoalveolar lavage fluid as novel biomarkers for sarcoidosis
por: Horimasu, Yasushi, et al.
Publicado: (2021)

AGER rs2070600 polymorphism elevates neutrophil-lymphocyte ratio and mortality in metastatic lung adenocarcinoma
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2017)

Cerebral embolism during edoxaban administration for venous thromboembolism in a patient with lung adenocarcinoma: A case report
por: Nakao, Satoshi, et al.
Publicado: (2019)

High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery
por: Takao, Shun, et al.
Publicado: (2019)

Performance Status Is a Risk Factor for Depression before the Diagnosis of Lung Cancer Patients
por: Miwata, Kei, et al.
Publicado: (2018)

D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report
por: Matsumoto, Yu, et al.
Publicado: (2021)

Pneumatosis Intestinalis following Radiation Esophagitis during Chemoradiotherapy for Lung Cancer: A Case Report
por: Ito, Noriaki, et al.
Publicado: (2021)

Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial–mesenchymal transition in lung endothelial cells
por: Daido, Wakako, et al.
Publicado: (2023)

Effect of baricitinib in patients with coronavirus disease 2019 and respiratory failure: A propensity score-matched retrospective cohort study
por: Tanimoto, Takuya, et al.
Publicado: (2022)

Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2018)

Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma
por: Okumoto, Joe, et al.
Publicado: (2020)

Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive‐stage small cell lung cancer: Two case reports
por: Watari, Naokazu, et al.
Publicado: (2021)

Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activity
por: Takahashi, Hiroshi, et al.
Publicado: (2021)

Two Cases of Cranial Nerve Metastasis Treated with Radiotherapy and Chemotherapy in Patients with Lung Adenocarcinoma
por: Kobayashi, Erika, et al.
Publicado: (2020)

IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis
por: Nakanishi, Yu, et al.
Publicado: (2021)

Pneumonia and Meningoencephalitis Due to Varicella-zoster Virus Reinfection and Epstein-Barr Virus Reactivation in a Patient with Rheumatoid Arthritis
por: Ito, Noriaki, et al.
Publicado: (2022)

Pulmonary Alveolar Proteinosis with Severe Respiratory Failure Improved by Segmental Lung Lavage with Fiberoptic Bronchoscopy under General Anesthesia
por: Matsumoto, Yu, et al.
Publicado: (2021)

Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer
por: Hamai, Kosuke, et al.
Publicado: (2023)

Inhibition of PAI‐1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer‐associated fibroblasts
por: Masuda, Takeshi, et al.
Publicado: (2019)

Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
por: Yamaguchi, Kakuhiro, et al.
Publicado: (2020)

Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis
por: Yamada, Takahiro, et al.
Publicado: (2019)

Pulmonary arteriovenous malformation exhibiting recanalization >10 years after coil embolization: Two case reports
por: Takao, Shun, et al.
Publicado: (2020)

A machine-learning based approach to quantify fine crackles in the diagnosis of interstitial pneumonia: A proof-of-concept study
por: Horimasu, Yasushi, et al.
Publicado: (2021)

First‐line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptor G719S and de novo T790M mutations
por: Ito, Noriaki, et al.
Publicado: (2022)

Preserved ratio impaired spirometry with or without restrictive spirometric abnormality
por: Miura, Shinichiro, et al.
Publicado: (2023)

Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis
por: Hamai, Kosuke, et al.
Publicado: (2016)

Need for a high-specificity test for confirming weakly positive result in an immunochromatographic SARS-CoV-2-specific antigen test: A case report
por: Tanimoto, Takuya, et al.
Publicado: (2021)

Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer
por: Daido, Wakako, et al.
Publicado: (2022)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust regulatory T cell induction in murine bleomycin-induced pulmonary fibrosis
por: Takao, Shun, et al.
Publicado: (2021)

Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition
por: Tokumo, Kentaro, et al.
Publicado: (2023)

Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression
por: Shimoji, Kiyofumi, et al.
Publicado: (2023)

Comparison of time to failure of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy: a consecutive analysis of patients having NSCLC with high PD-L1 expression
por: Takumida, Hiroshi, et al.
Publicado: (2021)

Pembrolizumab‐caused polyradiculoneuropathy as an immune‐related adverse event
por: Kurashige, Takashi, et al.
Publicado: (2021)

Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor–Induced Interstitial Lung Disease Among Patients With Nonlung Cancers
por: Shimoji, Kiyofumi, et al.
Publicado: (2020)

Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer
por: Wakabayashi, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q3jh8jcn9l9lmc4bc510hd75j9